Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Cariprazine Adds Bipolar Indication in Singapore: Mitsubishi Tanabe
February 3, 2022
- Boehringer to Rejig Japan Sales Offices as Work Style Shifts, No Rep Cut Planned
February 2, 2022
- Sumitomo Dainippon Expects to Get Back on Growth Track in FY2025 after Latuda’s LOE: President
February 2, 2022
- Tau Antibody Licensed to US Merck Enters Clinic: Teijin
February 2, 2022
- Sumitomo Dainippon’s 9-Month Profit Sinks 33.5% on US Promotions, Other Factors
February 1, 2022
- Lenvima/Keytruda Combo Approved in Taiwan for Advanced RCC
February 1, 2022
- Buoyant Opdivo and Forxiga Drive Ono’s Growth in April-December
February 1, 2022
- Daiichi Sankyo Initiates COVID-19 Booster Study in Japan
February 1, 2022
- Kyowa Kirin Files Ophthalmic Mitomycin C Agent in Japan
February 1, 2022
- Oncolys’ Nucleocapsid Inhibitor Effective against Omicron, PI Launch by Year-End
February 1, 2022
- Shionogi’s April-Dec. Operating Profit Tumbles 40%-Plus on Antibiotic Promotion, COVID R&D
February 1, 2022
- Daiichi Sankyo’s Revenue Rises 9.8% in April-December on Upbeat Mainstays
February 1, 2022
- Ivermectin Shows Antiviral Effects against Omicron: Kowa
February 1, 2022
- Biogen/Eisai Sets Primary Target in Aduhelm Confirmatory Study
January 31, 2022
- LEO Pharma Files Tralokinumab for Atopic Dermatitis in Japan
January 31, 2022
- Fujifilm to Buy Atara’s Cell Therapy Manufacturing Facility in US
January 28, 2022
- Otsuka Partners with VR Solution Firm to Offer Social Skills Training for Mental Health
January 28, 2022
- Otsuka Slashes Full Year Profits for 2021
January 28, 2022
- Jardiance’s New Indication Targets Around Half of Chronic Heart Failure Patients: Professor
January 28, 2022
- Yakult Honsha to Launch Velcade Generic in March
January 27, 2022
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…